{"id":"https://genegraph.clinicalgenome.org/r/695026c7-c470-4cb4-8f64-c4c9cbc54d2bv1.1","type":"EvidenceStrengthAssertion","dc:description":"The relationship between the NAGLU gene and mucopolysaccharidosis type IIIB (MPS IIIB), an autosomal recessive lysosomal storage disorder, was evaluated using the ClinGen Clinical Validity Framework as of June 29, 2022. NAGLU encodes alpha-N-acetylglucosaminidase, a lysosomal enzyme that catalyzes the hydrolysis of terminal non-reducing N-acetyl-D-glucosamine residues in the degradation of heparan sulfate, a glycosaminoglycan (GAG) (PMID: 8650226). Among individuals with MPS IIIB, alpha-N-acetylglucosaminidase deficiency results in accumulation of incompletely degraded oligosaccharides in lysosomes in the brain and other tissues, resulting in neurodegeneration with variable extra-neurologic manifestations (as reviewed in PMID: 18392742, PMID: 11668611). \n\nThe disease mechanism of MPS IIIB is loss of function. MPS IIIB was first reported in 1973 (Neufeld, Personal Communication. Bethesda, Md. 1973) and the first report of biallelic variants in NAGLU among patients with MPS IIIB was published in 1996 (PMID: 8650226). Both case-level (genetic) and experimental evidence support the relationship between MPS IIIB and NAGLU. Reported causal variants include missense, nonsense, frameshift, and splice-altering variants, as well as larger intragenic deletions (PMID: 11668611). In total, 10 variants from six probands in five publications were curated. Although there is additional published case-level evidence available, the maximum score for genetic evidence (12 points) has already been reached. \n\nExperimental evidence for the relationship between NAGLU and MPS IIIB includes the biochemical function of the gene product (the alpha-N-acetylglucosaminidase enzyme) being consistent with the clinical and biochemical findings identified individuals with MPS IIIB (PMID: 8650226, PMID:18392742, PMID:11668611), the biochemical and clinical features of a NAGLU knockout mouse animal (PMID: 10588735), and the impact of gene therapy among human MPS IIIB patients (PMID: 28713035). Additional experimental evidence is available, but the maximum score for experimental evidence (6 points) has already been reached.\n\nIn sum, NAGLU is definitively associated with MPS IIIB. The association has been repeatedly demonstrated in both clinical and research settings, and has been upheld over time. This clinical validity classification was approved by the ClinGen Lysosomal Diseases GCEP on August 2, 2022 (SOP v9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/695026c7-c470-4cb4-8f64-c4c9cbc54d2b","GCISnapshot":"https://genegraph.clinicalgenome.org/r/7ee5629a-f6c2-4187-a802-d570f7180478","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:sopChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/7ee5629a-f6c2-4187-a802-d570f7180478_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10110","date":"2024-03-02T20:04:37.952Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/7ee5629a-f6c2-4187-a802-d570f7180478_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10110","date":"2022-08-22T16:00:00.000Z","role":"Approver"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7ee5629a-f6c2-4187-a802-d570f7180478_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7ee5629a-f6c2-4187-a802-d570f7180478_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/822e728c-89b8-4c67-a5f8-21a1295f05ad","type":"EvidenceLine","dc:description":"Per ClinGen LD GCEP guidelines, gene products that have a well-established function in a metabolic pathway, supported by multiple studies over many years, and discussed in review papers are scored 2 points","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2f1811b6-6fe9-4bf4-8fe8-0960805ccf1c","type":"Finding","dc:description":"NAGLU encodes the alpha-N-acetylglucosaminidase enzyme (PMID: 8650226), which is deficient among individuals with MPS type IIIB (as reviewed in PMID: 11668611) \nAlpha-N-acetylglucosaminidase is a lysosomal enzyme involved in the degradation of heparan sulfate, a glycosaminoglycan (GAG), via catalyzing the hydrolysis of terminal non-reducing N-acetyl-D-glucosamine residues (as reviewed in PMID: 18392742) \nNAGLU deficiency leads to accumulation of incompletely degraded oligosaccharides in lysosomes in the brain and other tissues, resulting in neurodegeneration with variable extra-neurologic manifestations (as reviewed in PMID: 18392742) ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8650226","rdfs:label":"NAGLU encodes alpha-N-acetylglucosaminidase","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/7ee5629a-f6c2-4187-a802-d570f7180478_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f7b45f48-aa5b-4b61-8a52-2c0bed606922","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7d1573ea-5776-4023-a4bc-dd8f9d435491","type":"Finding","dc:description":"Patients showed sustained increase in α-N-acetylglucosaminidase enzyme production and improved neurocognitive function\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28713035","rdfs:label":"NAGLU gene therapy","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityHumanRescueCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/cff56924-f037-419d-b5ce-0512a9481594","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/efa58b0e-a66d-44af-8c26-8accf2a43a37","type":"Finding","dc:description":"Knockout mice show deficiency in alpha-N-acetylglucosaminidase, neurobehavioral anomalies, and ‘had massive accumulation of heparan sulfate in liver and kidney’ and ‘elevation of gangliosides G(M2) and G(M3) in brain.’","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10588735","rdfs:label":"NAGLU knockout mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/7ee5629a-f6c2-4187-a802-d570f7180478_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fc8c9115-5b37-4878-95da-5fea3d459dd5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fc8c9115-5b37-4878-95da-5fea3d459dd5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9832037","rdfs:label":"Patient 10","allele":{"id":"https://genegraph.clinicalgenome.org/r/c3abbe56-85e5-4499-bf36-cc6f914f6f3b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000263.4(NAGLU):c.1876C>T (p.Arg626Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA115043"}},"firstTestingMethod":"PCR","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/d6c5dea7-03b6-43a4-85f2-20a127c76aca_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9832037","allele":{"id":"https://genegraph.clinicalgenome.org/r/c3abbe56-85e5-4499-bf36-cc6f914f6f3b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/d6c5dea7-03b6-43a4-85f2-20a127c76aca","type":"EvidenceLine","dc:description":"made 0.75 for 1.5pts total to avoid double-counting for homozygous variant","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d6c5dea7-03b6-43a4-85f2-20a127c76aca_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/db913885-a8a1-4b13-8c86-6fd8a94f32fb_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/db913885-a8a1-4b13-8c86-6fd8a94f32fb","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14984474","rdfs:label":"Patient 18","allele":[{"id":"https://genegraph.clinicalgenome.org/r/a0fe6da5-a6c4-4b13-a423-30759025e4eb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000263.4(NAGLU):c.419A>G (p.Tyr140Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8576764"}},{"id":"https://genegraph.clinicalgenome.org/r/0437f2f4-7e30-4019-99c3-df9e981369c4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000263.4(NAGLU):c.334_358del (p.Arg112SerfsTer2)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573130377"}}],"firstTestingMethod":"PCR","secondTestingMethod":"SSCP","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/285760e2-3f84-433b-8947-5e1fb7c791e8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14984474","allele":{"id":"https://genegraph.clinicalgenome.org/r/a0fe6da5-a6c4-4b13-a423-30759025e4eb"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/03373846-d3c3-4b6a-a6b9-bd632973b6a1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14984474","allele":{"id":"https://genegraph.clinicalgenome.org/r/0437f2f4-7e30-4019-99c3-df9e981369c4"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/285760e2-3f84-433b-8947-5e1fb7c791e8","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/285760e2-3f84-433b-8947-5e1fb7c791e8_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/285760e2-3f84-433b-8947-5e1fb7c791e8_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional data (PMID: 9443878): in transfected chinese hamster ovary cells, led to <5% of wild-type enzyme activity","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/03373846-d3c3-4b6a-a6b9-bd632973b6a1","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/03373846-d3c3-4b6a-a6b9-bd632973b6a1_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/eab73a54-1079-46e3-97ef-4e118f0aa23a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eab73a54-1079-46e3-97ef-4e118f0aa23a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9443875","rdfs:label":"Patient F","allele":[{"id":"https://genegraph.clinicalgenome.org/r/443ade8c-2ab2-4888-9e9b-63957b10e675","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000263.4(NAGLU):c.2020C>T (p.Arg674Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/553061"}},{"id":"https://genegraph.clinicalgenome.org/r/7db42c61-f72e-46f6-8eca-a4b558f701ce","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000263.4(NAGLU):c.2021G>A (p.Arg674His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA115042"}}],"firstTestingMethod":"PCR","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/621fedae-0b86-420c-861a-507128a9ea7a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9443875","allele":{"id":"https://genegraph.clinicalgenome.org/r/443ade8c-2ab2-4888-9e9b-63957b10e675"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/8b8e2118-d801-41ef-b8e0-4f6e44313678_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9443875","allele":{"id":"https://genegraph.clinicalgenome.org/r/7db42c61-f72e-46f6-8eca-a4b558f701ce"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/8b8e2118-d801-41ef-b8e0-4f6e44313678","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8b8e2118-d801-41ef-b8e0-4f6e44313678_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/8b8e2118-d801-41ef-b8e0-4f6e44313678_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional data (PMID: 9443878): in transfected chinese hamster ovary cells, resulted in 3% of WT enzyme activity","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/621fedae-0b86-420c-861a-507128a9ea7a","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/621fedae-0b86-420c-861a-507128a9ea7a_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/5b71ba38-642d-484a-95ed-d7272fc9f9ee_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b71ba38-642d-484a-95ed-d7272fc9f9ee","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11153910","rdfs:label":"Patient 20","allele":{"id":"https://genegraph.clinicalgenome.org/r/c24b6b19-9808-465f-a2ed-d5ec44a77d57","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000263.4(NAGLU):c.678+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/1683236"}},"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/a0c9b4ba-8c04-470b-b66d-b9329efd313f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11153910","allele":{"id":"https://genegraph.clinicalgenome.org/r/c24b6b19-9808-465f-a2ed-d5ec44a77d57"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/a0c9b4ba-8c04-470b-b66d-b9329efd313f","type":"EvidenceLine","dc:description":"scored 1pt to yield 2pts total, thereby avoiding double-counting for homozygous variant","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a0c9b4ba-8c04-470b-b66d-b9329efd313f_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/a0c9b4ba-8c04-470b-b66d-b9329efd313f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional data: shown by RT-PCR analysis to result in aberrant splicing (produced transcripts lacking exons 2 and 3 or lacking exon 3) and in transfected COS cells, resulted in 23% of WT enzyme activity (PMID: 11153910)","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/5cff49b3-6581-4f8d-91b2-e4b7e6744bd7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5cff49b3-6581-4f8d-91b2-e4b7e6744bd7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9443875","rdfs:label":"Patient B","allele":{"id":"https://genegraph.clinicalgenome.org/r/30f224a0-ed94-4306-ac61-d947d0c29e7d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000263.4(NAGLU):c.507_516del (p.Ser169fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA115047"}},"firstTestingMethod":"PCR","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/c667fff4-072e-4d00-bc4d-2bbafd782281_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9443875","allele":{"id":"https://genegraph.clinicalgenome.org/r/30f224a0-ed94-4306-ac61-d947d0c29e7d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/c667fff4-072e-4d00-bc4d-2bbafd782281","type":"EvidenceLine","dc:description":"scored 0.75pts to yield 1.5pt total and thereby avoid double-counting for homozygous variant","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c667fff4-072e-4d00-bc4d-2bbafd782281_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/fbe2f614-b5d7-4d00-a7bd-49f3d001f6bb_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fbe2f614-b5d7-4d00-a7bd-49f3d001f6bb","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11068184","rdfs:label":"Patient 1","allele":[{"id":"https://genegraph.clinicalgenome.org/r/1030b004-a680-4f6a-830e-649ac04aa899","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000263.4(NAGLU):c.889C>T (p.Arg297Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA115045"}},{"id":"https://genegraph.clinicalgenome.org/r/a42224de-f7c9-4110-afc3-280dd0e21c10","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000263.4(NAGLU):c.2171_2172del (p.Val724fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/1346520"}}],"firstTestingMethod":"PCR","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/ca7270b3-95b0-42dc-bb8a-4c6738d6c779_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11068184","allele":{"id":"https://genegraph.clinicalgenome.org/r/1030b004-a680-4f6a-830e-649ac04aa899"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/fb5a9140-9627-4ba2-9198-81c84252acf8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11068184","allele":{"id":"https://genegraph.clinicalgenome.org/r/a42224de-f7c9-4110-afc3-280dd0e21c10"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/ca7270b3-95b0-42dc-bb8a-4c6738d6c779","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ca7270b3-95b0-42dc-bb8a-4c6738d6c779_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/ca7270b3-95b0-42dc-bb8a-4c6738d6c779_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 11068184: Supporting functional data - transfected Chinese hamster ovary cells showed <5% of WT NAGLU enzyme activity","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/fb5a9140-9627-4ba2-9198-81c84252acf8","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fb5a9140-9627-4ba2-9198-81c84252acf8_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/fb5a9140-9627-4ba2-9198-81c84252acf8_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 11068184: Supporting functional data - transfected Chinese hamster ovary cells showed <5% of WT NAGLU enzyme activity","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/9b7b0a18-2663-4aba-a07e-2e3d5e771814_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9b7b0a18-2663-4aba-a07e-2e3d5e771814","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11153910","rdfs:label":"Patient 9","allele":{"id":"https://genegraph.clinicalgenome.org/r/2f34be51-6aa2-43b9-8716-aacc63db5ba9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000263.4(NAGLU):c.1006G>T (p.Glu336Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8576915"}},"firstTestingMethod":"PCR","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/9c4063fc-db4c-4463-abf4-b42a798a8ce2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11153910","allele":{"id":"https://genegraph.clinicalgenome.org/r/2f34be51-6aa2-43b9-8716-aacc63db5ba9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/9c4063fc-db4c-4463-abf4-b42a798a8ce2","type":"EvidenceLine","dc:description":"adjusted to 1pt for 2pts total to avoid double-counting for homozygous variant","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9c4063fc-db4c-4463-abf4-b42a798a8ce2_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/9c4063fc-db4c-4463-abf4-b42a798a8ce2_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional data: in transfected COS cells, resulted in 29% of WT enzyme activity (PMID: 11153910)\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":7851,"specifiedBy":"GeneValidityCriteria10","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/s1zb2q4hoOQ","type":"GeneValidityProposition","disease":"obo:MONDO_0009656","gene":"hgnc:7632","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_7ee5629a-f6c2-4187-a802-d570f7180478-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}